Loading
institutionsInstitution
Sichuan Cancer Hospital
Sichuan Cancer Hospital in Chengdu is a large provincial cancer centre known for oesophageal and head and neck cancer radiotherapy and a partner of the city's ADC companies.
Also called: Sichuan Cancer Hospital and Institute四川省肿瘤医院
Overview
Sichuan Cancer Hospital in Chengdu, also the Sichuan Cancer Hospital and Institute, is a large provincial cancer centre known for oesophageal and head and neck cancer radiotherapy and for partnering with the city's antibody-drug conjugate companies. Its radiotherapy programme is among the largest in China, it treats high oesophageal cancer volumes from Sichuan's high-incidence areas, and it takes part in trials with the Chengdu-based Sichuan Kelun-Biotech and SystImmune, part of Sichuan Biokin, on their ADCs. OnCo connects it to oesophageal cancer and head and neck squamous cell carcinoma and to both companies. Whether a provincial hospital can be both trial site and neighbour to the sponsors without conflicts is a fair question. Its radiation oncology and ADC trial programmes are listed below.
Location
Chengdu, CN
Type
cancer center
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#484 · 8 points (0 Newsweek + 0 NCI + 8 from 4 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Sichuan Cancer Hospital, including child institutions. 780 works · 6,945 citations · 75% open access · 20% clinical trials · 6% reviews.
Oncology works per year
992022
1302023
1442024
2192025
1882026
Most works
- Qiuling Shi20 works
- Yongdong Jin15 works
- Meijuan Huang15 works
- Wei Dai14 works
- Guonan Zhang13 works
- Hongfan Yu12 works
- Huaichao Luo12 works
- Panwen Tian12 works
- Xing Wei12 works
- Ying Cheng11 works
Most cited
- Radiation oncology
- Oesophageal and head and neck cancer
- ADC trials
Similar pages
- InstitutionJiangsu Cancer Hospital
Shares Oesophageal cancer and the tag china.
- TrialRATIONALE-302
Shares Oesophageal cancer and the tag china.
- TrialJUPITER-06
Shares Oesophageal cancer and the tag china.
- TreatmentSintilimab
Shares Oesophageal cancer and the tag china.
- CompanyJiangsu Hengrui Pharmaceuticals
Shares Oesophageal cancer and the tag china.
- TrialA Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
Shares SystImmune / Sichuan Biokin, Head and neck squamous cell carcinoma.
- TrialSKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Shares Sichuan Kelun-Biotech, Oesophageal cancer.
- TrialA Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
Shares SystImmune / Sichuan Biokin, Head and neck squamous cell carcinoma.